The Health Resources and Services Administration is again pushing to include rebates in the drug discount program after a failed attempt earlier this year. Hospitals railed against the announcement, ...

The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain ...

A federal court has rejected a lawsuit by several drugmakers that sought to change the 340B Drug Pricing Program from an upfront payment model to a backend rebate structure. Thursday's decision in U.S ...

The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, ...

It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B.

​A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to ...

The Health Resources & Services Administration has unveiled its formal plans for a revised version of its contentious 340B ...

Forbes contributors publish independent expert analyses and insights. Anthony T. Lo Sasso is Professor of Public Affairs at UW-Madison This voice experience is generated by AI. Learn more. This voice ...

The 340B Drug Pricing Program, meant for low-income patients to get cheaper medications, is being exploited. Its loopholes must be closed.